| __timestamp | CymaBay Therapeutics, Inc. | Xenon Pharmaceuticals Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 8185000 | 5496000 |
| Thursday, January 1, 2015 | 8871000 | 9786000 |
| Friday, January 1, 2016 | 9645000 | 6792000 |
| Sunday, January 1, 2017 | 12387000 | 7313000 |
| Monday, January 1, 2018 | 14381000 | 8382000 |
| Tuesday, January 1, 2019 | 19238000 | 10803000 |
| Wednesday, January 1, 2020 | 17425000 | 12944000 |
| Friday, January 1, 2021 | 23040000 | 21967000 |
| Saturday, January 1, 2022 | 25116000 | 32810000 |
| Sunday, January 1, 2023 | 51953000 | 46542000 |
Unveiling the hidden dimensions of data
In the competitive world of biotechnology, managing operational costs is crucial. This analysis compares the Selling, General, and Administrative (SG&A) expenses of CymaBay Therapeutics, Inc. and Xenon Pharmaceuticals Inc. from 2014 to 2023. Over this period, CymaBay's SG&A expenses surged by over 500%, peaking at $51.95 million in 2023. Meanwhile, Xenon Pharmaceuticals saw a similar upward trend, with expenses increasing by approximately 750%, reaching $46.54 million in the same year.
This financial trajectory highlights the dynamic nature of the biotech sector, where strategic spending can be a catalyst for innovation and market leadership.
Selling, General, and Administrative Costs: Novo Nordisk A/S vs CymaBay Therapeutics, Inc.
Selling, General, and Administrative Costs: Teva Pharmaceutical Industries Limited vs Xenon Pharmaceuticals Inc.
Cost Management Insights: SG&A Expenses for Catalent, Inc. and CymaBay Therapeutics, Inc.
R&D Spending Showdown: CymaBay Therapeutics, Inc. vs Xenon Pharmaceuticals Inc.
Comparing SG&A Expenses: CymaBay Therapeutics, Inc. vs PTC Therapeutics, Inc. Trends and Insights
Comparing SG&A Expenses: CymaBay Therapeutics, Inc. vs Novavax, Inc. Trends and Insights
SG&A Efficiency Analysis: Comparing Apellis Pharmaceuticals, Inc. and Xenon Pharmaceuticals Inc.
Who Optimizes SG&A Costs Better? Viking Therapeutics, Inc. or Xenon Pharmaceuticals Inc.
Who Optimizes SG&A Costs Better? Xenon Pharmaceuticals Inc. or ACADIA Pharmaceuticals Inc.
Selling, General, and Administrative Costs: Xenon Pharmaceuticals Inc. vs Protagonist Therapeutics, Inc.
Selling, General, and Administrative Costs: Xenon Pharmaceuticals Inc. vs Xencor, Inc.
Xenon Pharmaceuticals Inc. or Viridian Therapeutics, Inc.: Who Manages SG&A Costs Better?